Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 8:32 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 457–480 of 4,271 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ADM Clear all

Conditions: Oral Cancer
Interventions: Imaging using intraoral cameras; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Melanoma, Adolescents
Interventions: Skin cancer prevention educational presentation and activities; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 11 Years to 21 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: HIV - Human Immunodeficiency Virus, HIV Antiretroviral Therapy (ART) Adherence, mHealth Application, mHealth Intervention, Continuum of Care, Youth With HIV
Interventions: MindBodyU Intervention; Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: 16 Years to 25 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Transmission, Blood, Recipient/Donor
Interventions: Not listed
Lead sponsor: Haemonetics Corporation; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 161 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Accidental Falls
Interventions: Balance Training Intervention; Other
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 65 Years and older
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2003
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Depression, Major Depressive Disorder, Dysthymic Disorder, Depressive Symptoms, Type 2 Diabetes, PreDiabetes, Insulin Resistance
Interventions: Good Days Ahead (GDA), Problem Solving Treatment in Primary Care (PST-PC), Antidepressant Medications, Active Control; Behavioral · Drug · Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Hearing Loss
Interventions: Attention to Variability (ATV), Placebo; Behavioral · Other
Lead sponsor: Harvard University; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Ventilatory Depression, Postoperative Respiratory Failure
Interventions: Oxygen gas; Other
Lead sponsor: Stanford University; Other
Eligibility: 20 Years to 90 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Stanford, California

Conditions: Brain Cancer, CNS Cancer
Interventions: FACBC, Methionine, PET Scan; Drug · Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: Not listed
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Quality of Life, Pelvic Organ Prolapse, Prolapses, Vaginal Vault
Interventions: Dexamethasone, Normal saline; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Weston, Florida

Conditions: Tobacco Use Disorder
Interventions: varenicline, nicotine patch; Drug
Lead sponsor: Roswell Park Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Opioid Use
Interventions: Acetaminophen, Fentanyl, Propofol; Drug
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 56 Years · Female only
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Smokeless Tobacco Cessation
Interventions: All Nations Snuff Out Smokeless, Healthy Living; Behavioral
Lead sponsor: Lehigh University; Other
Eligibility: 18 Years and older
Enrollment: 384 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Bethlehem, Pennsylvania

Conditions: Drug/Agent Toxicity by Tissue/Organ, Leukemia
Interventions: asparaginase, cyclophosphamide, cytarabine, dexamethasone, dexrazoxane hydrochloride, doxorubicin hydrochloride, etoposide, leucovorin calcium, mercaptopurine, methotrexate, methylprednisolone, pegaspargase, prednisolone, therapeutic hydrocortisone, vincristine sulfate, radiation therapy; Drug · Radiation
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 1 Year to 18 Years
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2019
U.S. locations: 5
States / cities: Boston, Massachusetts • New York, New York • Rochester, New York + 2 more

Conditions: Spinal Fusion Acquired, Spinal Stenosis, Lesions of Lumbosacral Intervertebral Disc, Spinal Diseases
Interventions: Dexmedetomidine, 0.9% Saline; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Obsessive-Compulsive Disorder
Interventions: Celecoxib; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 55 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Newly Diagnosed Ewing Sarcoma
Interventions: Cyclophosphamide, Doxorubicin, Vincristine, Ifosfamide, Etoposide, Surgery, Radiation Therapy*, Temozolomide, Irinotecan, Mesna, Dexrazoxane, G-CSF; Drug · Device · Procedure + 1 more
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 1 Year to 40 Years
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Prostate Cancer
Interventions: Whole-food, Plant-Based Diet, General Nutritional Counseling; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 45 Years to 99 Years · Male only
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 3
States / cities: Baltimore, Maryland • New York, New York

Conditions: Pleuropulmonary Blastoma
Interventions: Vincristine, Dactinomycin, Cyclophosphamide, Ifosfamide, Doxorubicin; Drug
Lead sponsor: Children's Hospitals and Clinics of Minnesota; Other
Eligibility: Up to 21 Years
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2035
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Relapsing Remitting Multiple Sclerosis
Interventions: Implant Procedure, Disease-Modifying Therapies (DMTs), Active stimulation, Non-active stimulation; Procedure · Drug · Device
Lead sponsor: SetPoint Medical Corporation; Industry
Eligibility: 22 Years to 60 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 9
States / cities: Irvine, California • Atlanta, Georgia • Baltimore, Maryland + 6 more

Conditions: Breast Cancer, Arthralgia
Interventions: Education and exercise intervention, Education and General Exercise; Behavioral
Lead sponsor: George Washington University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Intimate Partner Violence, Depression, Anxiety, PTSD
Interventions: Self-Compassion, Health, and Empowerment (SHE), The Control Condition; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Austin, Texas

Conditions: HIV/AIDS
Interventions: Risk reduction behavioral intervention, Wellness Promotion Intervention; Behavioral
Lead sponsor: Temple University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cancer Survivor, Pain, Chemotherapy Induced Peripheral Neuropathy, Function, Fall Risk, Balance, Quality of Life
Interventions: Somatic Yoga and Meditation (SYM); Behavioral
Lead sponsor: Stockton University; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Atlantic City, New Jersey • Pomona, New Jersey

Search by objective public record fields.

Oral Pathology Asynchronous Telementoring Pilot Study

Sun Protection and Tanning Awareness in Rural Schools

Improving the HIV Care Continuum With mHealth Technology

Procedure For The Reference Range Study For Absolute MA

Training Improves Balance Control

eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk

Mindfulness Intervention and Symptom Variability in Hearing

Hyperoxia on Ventilation During Recovery From General Anesthesia

Imaging Brain Tumors With FACBC and Methionine

Does Dexamethasone Administration Improve Recovery In Patients Undergoing Minimally Invasive Sacrocolpopexy?

Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers

Rectal Acetaminophen Use During Oocyte Retrievals to Reduce Post-Operative Opioid Utilization

Testing ANSOS for Efficacy in Multi-Tribal Urban Communities

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Intraoperative Infusion of Precedex to Reduce Length of Stay After Lumbar Spine Fusion

Neuroinflammation in Patients With OCD

Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma

Whole-Food Plant-Based Diet to Control Weight and MetaboInflammation in Overweight/Obese Men With Prostate Cancer

International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer

Feasibility Study for Abused Chinese Immigrant Women

A Couple-based HIV Prevention Intervention to Promote HIV Protection Among Latino Male Couples

Somatic Yoga and Meditation for Cancer Survivors With Pain From Neuropathy